Related Experiment Video
Updated: Aug 20, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
[Therapy of bronchial asthma in childhood]
1Semmelweis Egyetem, Altalános Orvostudományi Kar, I. Gyermekklinika, Budapest. cser@gyer1.sote.hu
Insights
This study summarizes current childhood bronchial asthma treatments, focusing on reducing allergic airway inflammation and symptoms. Key therapies include allergen avoidance, medication, and immunotherapy.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Respiratory Medicine
Context:
- Childhood bronchial asthma affects 1-30% of children globally, characterized by allergic airway inflammation.
- Effective management requires addressing environmental triggers, pharmacotherapy, and immunotherapy.
Purpose:
- To provide a comprehensive summary of current therapeutic strategies for pediatric bronchial asthma.
- To outline the principles of allergen avoidance, drug selection based on severity, and immunotherapy.
Summary:
- Therapy focuses on diminishing allergic inflammation and alleviating asthma symptoms.
- Treatment modalities include environmental allergen/trigger reduction, pharmacotherapy guided by WHO severity steps, and allergen-specific immunotherapy.
- Key drug properties and practical therapeutic approaches are detailed, alongside immunotherapy features.
Impact:
- Informs healthcare providers on evidence-based asthma management in children.
- Aims to improve patient outcomes by optimizing therapeutic interventions.
- Highlights the multi-faceted approach needed for effective pediatric asthma control.
Abstract:
The aim of the study is to summarize the up-to-date therapy of bronchial asthma in childhood. Many children in the world (1-30%) suffer from this disease. The essence of it is the special allergic inflammation of the bronchi, so the chief aim of the therapy is the diminution of this inflammation and the ceasing of the actual symptoms. The therapy is based on three possibilities: diminution of the causative allergens and trigger factors in the environment, drug therapy, and allergen vaccination (immunotherapy). The drug therapy is considered on the four step severity criteria of the WHO. The study makes known the basic properties of the important drugs and the practice of the therapy; gives a list of elimination possibilities and mentions the chief features of immunotherapy.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-I: Introduction
